@duttonjonathan @Rollinopi @Stephen13585223 With 62% of shares held by Directors and insiders $PRTG will never get to ii having comparable holdings as its peers. Look at the skin in the game those in the company have.
@duttonjonathan This makes no sense. Major shareholders like Jim show support investing heavily in $PRTG. You can only claim they aren't supporting when they sell. Your tweets imply you are a LTH whilst the content implies you hold a short position or want to buy back when the sp has fallen.
@duttonjonathan @RichieKennett @duttonjonathan you were happy to buy $PRTG at c$20. It makes no sense to ask why Sultan of Oman isn't buying at these levels. Why aren't You? Your tweets imply you hold a short position rather than being a LTH as you state. Good luck.
Hear from Dr. Karadimitris and Dr. Kronenberg in our recent KOL webinar event, discussing how #iNKTs could improve #ImmunoOncology. Register to watch the replay here to learn more: https://t.co/JqrL09mJ3Y
$PRTG
The timeline is far sooner for revenue generated from PORT-2&3, multi $billion revenue inbound
Safety Data due for both in Dec 21
2022 will be transformational for all shareholders
Only 2 of 5 drugs in their pipeline
The same BOD spun off Biohaven, now an $8bn company
$PRTG
PORT-1 multiple phase 2 data read outs due 2-3 months +Invincible Trial early data
https://t.co/2BJYqZcf2t
NCT03058289
NCT04781725
Word is Intensity IPO backed with Portage stake increase
INT230-6 combo $BMY $MRK
Results exceptional-kills cancer cells,Deal inevitable
Our #immunooncology programs incorporate technology to optimally engage the immune system to attack #cancer. Read more about how we are leveraging #iNKT therapy to address multiple cancer types: https://t.co/54lckifCry
Today, the Portage team had the chance to ring the @Nasdaq opening bell at Times Square in New York City! What a great way to celebrate our Nasdaq listing under $PRTG and our work in #ImmunoOncology, including progress on our #iNKT programs, in 2021.
I would encourage anyone who is looking at investment in any #oncology and #cancer biotech or leading Pharmeceutical company to listen to the interview with Ian Walters at Portage Biotech. This #iNKT technology with combination is going to revolutionise cancer treatments!
$PRTG
This man threw a pint of beer at me on the escalators at Liverpool St around 5:10pm today and ran away when security tried to stop him. Please RT and help me find this mf @TfL@BTP@metpoliceuk
Today, our CEO Dr. Ian Walters issued a corporate update in a letter to shareholders, highlighting clinical development and financing milestones that have positioned the company for accelerated development of innovative cancer treatments. Read more here: https://t.co/K8tK0SQ9B3